Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Section 3: Production and Compounding
3PC-002
PRELIMINARY RESULTS ON THE USE OF ORAL REHYDRATION SOLUTION IN THE FORM OF GELATO FOR REHYDRATION OF CHILDREN WITH ACUTE GASTROENTERITIS
3PC-001
MAGISTRAL FORMULATION OF 10% SUCRALFATE ENEMAS IN PROCTITIS
3PC-037
CLEANING VALIDATION OF SOLUTION PRODUCTION IN A HOSPITAL PHARMACY
3PC-039
CENTRALISED NON-HAZARDOUS INTRAVENOUS COMPOUNDING: IMPROVEMENT OF CLINICAL PRACTICE
3PC-035
SO, HAPPY? AUTOMATED NOMINATIVE DISPENSATION: SATISFACTION SURVEY OF THE NURSING STAFF
3PC-034
SCREENING FOR PHYSICOCHEMICAL INCOMPATIBILITIES OF CYTOTOXIC DRUGS AFTER RECONSTITUTION: THE CASE OF METHOTREXATE
3PC-033
IN VITRO PHYSICOCHEMICAL INTERACTIONS STUDY BETWEEN IRON AND ANTICANCER DRUGS ADMINISTRATED IN HOSPITAL
3PC-027
AMIFAMPRIDINE AND PYRIDOSTIGMINE HARD CAPSULES FOR TREATMENT OF CONGENITAL MYASTHENIC SYNDROMES: A CASE REPORT
3PC-026
PHYSICOCHEMICAL STABILITY OF ROCURONIUM BROMIDE INJECTION SOLUTION 10 MG/ML AS BULK SOLUTION AND IN 10 ML READY-TO-ADMINISTER SYRINGES
3PC-015
MEDIA-FILL SIMULATION TESTS OF INFUSION BAGS PREPARED IN SERIES BY THE COMPOUNDING ROBOT APOTECACHEMO
3PC-012
STABILITY OF CEFUROXIME 80 MG/ML SOLUTION IN READY-TO-ADMINISTER POLYPROPYLENE SYRINGES
3PC-009
PHYSICOCHEMICAL STABILITY OF INTRAVENOUS INJECTION OF A GENERIC PRODUCT OF FUROSEMIDE PREPARED IN POLYPROPYLENE SYRINGES
3PC-008
FORMULATION AND STABILITY STUDY OF THE EXTEMPORANEOUS ORAL SOLUTIONS OF CARDIOLOGIC DRUGS FOR PERSONALISED THERAPY OF NEWBORNS
3PC-003
PAEDIATRIC PARENTERAL NUTRITION ON WEEKENDS: WHO PREPARES? SURVEY OF COUNTRY’S HOSPITALS
3PC-017
TIME SAVINGS AND IMPROVED QUALITY ASSURANCE OF INTRAVENOUS CYTOSTATICS WITH SEMIAUTOMATED DOSE-BANDING
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
next ›
last »
Follow Us